secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001193125-26-036792
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sangamo raises ~$25M in underwritten offering of common stock and warrants; amends prior warrants
--------------------------------------------------------------------------------

- Offering of 35.19M shares + pre-funded warrants for 17.79M shares, each with a purchase warrant for 52.98M shares.
- Combined price per share+ warrant is $0.4719; pre-funded warrant+ warrant at $0.4619; gross proceeds ~$25M.
- Existing warrants held by investor repriced from $1.00 to $0.4719 and expiration extended to 5.5 years from closing.
- Closing expected February 4, 2026; proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000119312526036792/0001193125-26-036792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000119312526036792/d101629d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-036792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer